ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The TWISTER study, using a patient-specific primer for BCR-ABL, revealed that some CML patients who maintained UMRD after stopping IM had BCR-ABL DNA, leading to molecular relapse [4].